Published in J Bone Miner Metab on June 04, 2015
Identification and Functional Characterization of RSPO2 as a Susceptibility Gene for Ossification of the Posterior Longitudinal Ligament of the Spine. Am J Hum Genet (2016) 0.77
Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL. BMC Musculoskelet Disord (2017) 0.75
The Pathogenesis of Ossification of the Posterior Longitudinal Ligament. Aging Dis (2017) 0.75
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med (2013) 4.52
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J Exp Med (2004) 3.88
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J (2005) 3.61
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res (2006) 3.44
Ossification of the posterior longitudinal ligament of the spine. Clin Orthop Relat Res (1984) 2.45
Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res (2011) 2.00
Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab (2010) 1.87
An uncommon familial systemic disease of the skeleton: hyperostosis corticalis generalisata familiaris. Acta radiol (1955) 1.69
Association of diffuse idiopathic skeletal hyperostosis (DISH) and calcification and ossification of the posterior longitudinal ligament. AJR Am J Roentgenol (1978) 1.60
Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab (2011) 1.26
Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat Rev Endocrinol (2013) 1.23
Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res (2011) 1.23
Wnt signaling: a win for bone. Arch Biochem Biophys (2008) 1.17
High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study. J Bone Miner Res (2012) 1.12
Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. Ann Rheum Dis (2011) 1.09
A genome-wide association study identifies susceptibility loci for ossification of the posterior longitudinal ligament of the spine. Nat Genet (2014) 0.98
Immunohistochemical demonstration of bone morphogenetic protein-2 and transforming growth factor-beta in the ossification of the posterior longitudinal ligament of the cervical spine. Spine (Phila Pa 1976) (1992) 0.97
The extent of ossification of posterior longitudinal ligament of the spine associated with nucleotide pyrophosphatase gene and leptin receptor gene polymorphisms. Spine (Phila Pa 1976) (2005) 0.93
Sclerostin and DKK1 in primary hyperparathyroidism. Calcif Tissue Int (2013) 0.92
Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes. Bone (2013) 0.90
Serum Dkk-1 levels of DISH patients are not different from healthy controls. Joint Bone Spine (2011) 0.89
Insulin secretory response is positively associated with the extent of ossification of the posterior longitudinal ligament of the spine. J Bone Joint Surg Am (2001) 0.88
Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study. J Bone Miner Res (2013) 0.84
Bone mineral density in patients with ossification of the posterior longitudinal ligament in the cervical spine. J Bone Miner Metab (1999) 0.84
Long-term follow-up of the progression of ossification of the posterior longitudinal ligament. J Neurosurg Spine (2010) 0.83
Prevalence and progression of radiographic ossification of the posterior longitudinal ligament and associated factors in the Japanese population: a 3-year follow-up of the ROAD study. Osteoporos Int (2013) 0.82
Serum sclerostin levels in healthy men over 50 years of age. J Bone Miner Metab (2013) 0.81
Serum Dickkopf 1 levels in sclerostin deficiency. J Clin Endocrinol Metab (2013) 0.81
Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament. Eur Spine J (2011) 0.81
Increased bone mineral density and decreased prevalence of osteoporosis in cervical ossification of the posterior longitudinal ligament: a case-control study. Calcif Tissue Int (2012) 0.81
Significance of serum levels of type I procollagen peptide and intact osteocalcin and bone mineral density in patients with ossification of the posterior longitudinal ligaments. Calcif Tissue Int (1996) 0.80
[Affinity of estrogen binding in the cultured spinal ligament cells: an in vitro study using cells from spinal ligament ossification patients]. Nihon Seikeigeka Gakkai Zasshi (1995) 0.78
Significance of bone formation markers in patients with ossification of the posterior longitudinal ligament of the spine. Spine (Phila Pa 1976) (2003) 0.77
The efficacy of biochemical markers in patients with ossification of posterior longitudinal ligament of the spine. Spinal Cord (2000) 0.76
Bone mineral density of the lumbar spine in patients with ossification of the posterior longitudinal ligament of the cervical spine. J Spinal Disord (1995) 0.76